Why is Biogen Pharma falling/rising?

As of 18-Aug, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at 0.89, which reflects a decrease of 0.01 or 1.11%. The stock has underperformed its sector today by 2.96%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has shown negative returns over various periods, including a 3.26% decline over the past week and a significant 24.58% drop year-to-date. The delivery volume has also decreased by 12.93% compared to the 5-day average, indicating falling investor participation, which may contribute to the downward pressure on the stock price.
In the broader market context, the Sensex has shown a positive return of 0.83% over the past week, contrasting with Biogen Pharma's negative performance. While the benchmark has gained 4.01% year-to-date, Biogen Pharma's substantial decline of 24.58% highlights its underperformance relative to the market. This disparity suggests that investor sentiment may be more favorable towards the broader market, further exacerbating Biogen Pharma's struggles. Overall, the combination of poor stock performance, declining investor interest, and unfavorable comparisons to market benchmarks are contributing to the stock's current downward trajectory.